{"version":"1.0","provider_name":"South Africa Gazette","provider_url":"https:\/\/southafricagazette.com","author_name":"South Africa Gazette","author_url":"https:\/\/southafricagazette.com","title":"Merck And Ridgeback’s Molnupiravir, An Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval For Emergency In Japan","type":"rich","width":600,"height":338,"html":"
Merck And Ridgeback’s Molnupiravir, An Investigational Oral Antiviral COVID-19 Treatment, Receives Special Approval For Emergency In Japan<\/a><\/blockquote>